Cisplatin versus carboplatin in combination with paclitaxel as neoadjuvant regimen for triple negative breast cancer

BACKGROUND: Platinum salts have demonstrated sufficient efficacy and safety for consideration of their use in a neoadjuvant setting for triple negative breast cancer (TNBC). PATIENTS AND METHODS: We retrospectively analyzed 145 TNBC cases to compare the activity and tolerability of cisplatin and car...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Liang, Liu, Qi, Chen, Sheng, Shao, Zhiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716301/
https://www.ncbi.nlm.nih.gov/pubmed/29238206
http://dx.doi.org/10.2147/OTT.S145934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716301/
https://www.ncbi.nlm.nih.gov/pubmed/29238206
http://dx.doi.org/10.2147/OTT.S145934

Ejemplares similares